Search research articles
Contact Us
Filters
Showing results (41-50 of 188) with videos related to
Page
of 19
Sort By:
Haemostasis
|
February 22, 2001
Aspirin in the treatment and prevention of cardiovascular disease
J M Gaziano, P J Skerrett, J E Buring
Cancer
|
October 1, 1994
Nonsteroidal antiinflammatory drugs and colorectal cancer. A promising hypothesis but not yet proven
J E Buring, I M Lee, C H Hennekens
Archives of Internal Medicine
|
January 10, 1994
The benefits of aspirin in acute myocardial infarction. Still a well-kept secret in the United States
C H Hennekens, M A Jonas, J E Buring
JAMA
|
May 30, 1998
Concerns about run-in periods in randomized trials
R J Glynn, J E Buring, C H Hennekens
Statistics in Medicine
|
April 1, 1987
Implications of overviews of randomized trials
C H Hennekens, J E Buring, P R Hebert
JAMA
|
August 23, 1995
Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested
J E Buring, R J Glynn, C H Hennekens
IARC Scientific Publications
|
January 1, 1996
Methodological issues in the design of primary prevention trials
J M Gaziano, C H Hennekens, J E Buring
Annals of Epidemiology
|
September 1, 1993
Antiplatelet therapy and risk of stroke
C H Hennekens, M A Jonas, J E Buring
Archives of Internal Medicine
|
February 1, 1987
Cancer and venous thromboembolism
S Z Goldhaber, J E Buring, C H Hennekens
American Journal of Preventive Medicine
|
March 1, 1986
Alternative data sources in a case-control study of conjugated estrogens and cancer
J E Buring, C J Bain, C H Hennekens
Page
of 19
Search research articles
Search
Showing results (41-50 of 188) with videos related to
Sort By:
Page
of 19
Haemostasis
|
February 22, 2001
Aspirin in the treatment and prevention of cardiovascular disease
J M Gaziano, P J Skerrett, J E Buring
Cancer
|
October 1, 1994
Nonsteroidal antiinflammatory drugs and colorectal cancer. A promising hypothesis but not yet proven
J E Buring, I M Lee, C H Hennekens
Archives of Internal Medicine
|
January 10, 1994
The benefits of aspirin in acute myocardial infarction. Still a well-kept secret in the United States
C H Hennekens, M A Jonas, J E Buring
JAMA
|
May 30, 1998
Concerns about run-in periods in randomized trials
R J Glynn, J E Buring, C H Hennekens
Statistics in Medicine
|
April 1, 1987
Implications of overviews of randomized trials
C H Hennekens, J E Buring, P R Hebert
JAMA
|
August 23, 1995
Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested
J E Buring, R J Glynn, C H Hennekens
IARC Scientific Publications
|
January 1, 1996
Methodological issues in the design of primary prevention trials
J M Gaziano, C H Hennekens, J E Buring
Annals of Epidemiology
|
September 1, 1993
Antiplatelet therapy and risk of stroke
C H Hennekens, M A Jonas, J E Buring
Archives of Internal Medicine
|
February 1, 1987
Cancer and venous thromboembolism
S Z Goldhaber, J E Buring, C H Hennekens
American Journal of Preventive Medicine
|
March 1, 1986
Alternative data sources in a case-control study of conjugated estrogens and cancer
J E Buring, C J Bain, C H Hennekens
Page
of 19